Biotechnology Pharmaceuticals - Private Companies Report

Although most private companies in this industry are development-stage concerns, two have related sales of at least $50 million. An additional three commpanies have total sales of over $50 million, including products other than biotechnology pharmaceuticals. This report profiles over 110 private and start-up US companies (e.g., Boehringer Ingelheim, PRAECIS Pharmaceuticals) and lists them by indication and location. The report also forecasts industry demand, evaluates market share, and reviews acquistion and IPO trends.

Back to Top